Pub Date : 2025-06-01Epub Date: 2021-09-03DOI: 10.1055/a-1626-6669
Lara Franziska Stolzenbach, Florian Löcherbach, Katharina Wargenau, Randi Pose, Thomas Steuber, Zhe Tian, Lars Budäus, Derya Tilki, Markus Graefen, Daniel Köhler, Pierre I Karakiewicz, Markus Sauer, Ivayla Ilieva Apostolova, Tobias Maurer, Christoph Berliner
{"title":"Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities.","authors":"Lara Franziska Stolzenbach, Florian Löcherbach, Katharina Wargenau, Randi Pose, Thomas Steuber, Zhe Tian, Lars Budäus, Derya Tilki, Markus Graefen, Daniel Köhler, Pierre I Karakiewicz, Markus Sauer, Ivayla Ilieva Apostolova, Tobias Maurer, Christoph Berliner","doi":"10.1055/a-1626-6669","DOIUrl":"10.1055/a-1626-6669","url":null,"abstract":"","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":" ","pages":"e1"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39382236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2023-06-14DOI: 10.1055/a-2074-0027
Hyun-Yeol Nam, Seongho Seo, Myung Jun Lee, Keunyoung Kim, In Joo Kim, Kyoungjune Pak
{"title":"Correction: No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjects.","authors":"Hyun-Yeol Nam, Seongho Seo, Myung Jun Lee, Keunyoung Kim, In Joo Kim, Kyoungjune Pak","doi":"10.1055/a-2074-0027","DOIUrl":"10.1055/a-2074-0027","url":null,"abstract":"","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":" ","pages":"e4"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10005384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-01Epub Date: 2022-01-21DOI: 10.1055/a-1728-8828
Soo Bin Park, Chae Hong Lim, Won Ho Chang, Jung Hwa Hwang, Ji Young Lee, Young Hwan Kim, Jung Mi Park
{"title":"Correction: Diagnostic Value of Bone SPECT/CT Using 99mTc-Methylene Diphosphonate in Patients with Unspecified Chest Wall Pain.","authors":"Soo Bin Park, Chae Hong Lim, Won Ho Chang, Jung Hwa Hwang, Ji Young Lee, Young Hwan Kim, Jung Mi Park","doi":"10.1055/a-1728-8828","DOIUrl":"10.1055/a-1728-8828","url":null,"abstract":"","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":" ","pages":"e2"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39847023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01Epub Date: 2023-09-08DOI: 10.1055/a-2067-7642
Isabelle Miederer, Julian Manuel Michael Rogasch, Regina Fischer, Timo Fuchs, Constantin Lapa, Philipp Lohmann, Kuangyu Shi, Johannes Tran-Gia, Thomas Wendler, Dirk Hellwig
Digitization in the healthcare sector and the support of clinical workflows with artificial intelligence (AI), including AI-supported image analysis, represent a great challenge and equally a promising perspective for preclinical and clinical nuclear medicine. In Germany, the Medical Informatics Initiative (MII) and the Network University Medicine (NUM) are of central importance for this transformation. This review article outlines these structures and highlights their future role in enabling privacy-preserving federated multi-center analyses with interoperable data structures harmonized between site-specific IT infrastructures. The newly founded working group "Digitization and AI" in the German Society of Nuclear Medicine (DGN) as well as the Fach- und Organspezifische Arbeitsgruppe (FOSA, specialty- and organ-specific working group) founded for the field of nuclear medicine (FOSA Nuklearmedizin) within the NUM aim to initiate and coordinate measures in the context of digital medicine and (image-)data-driven analyses for the DGN.
{"title":"The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.","authors":"Isabelle Miederer, Julian Manuel Michael Rogasch, Regina Fischer, Timo Fuchs, Constantin Lapa, Philipp Lohmann, Kuangyu Shi, Johannes Tran-Gia, Thomas Wendler, Dirk Hellwig","doi":"10.1055/a-2067-7642","DOIUrl":"10.1055/a-2067-7642","url":null,"abstract":"<p><p>Digitization in the healthcare sector and the support of clinical workflows with artificial intelligence (AI), including AI-supported image analysis, represent a great challenge and equally a promising perspective for preclinical and clinical nuclear medicine. In Germany, the Medical Informatics Initiative (MII) and the Network University Medicine (NUM) are of central importance for this transformation. This review article outlines these structures and highlights their future role in enabling privacy-preserving federated multi-center analyses with interoperable data structures harmonized between site-specific IT infrastructures. The newly founded working group \"Digitization and AI\" in the German Society of Nuclear Medicine (DGN) as well as the Fach- und Organspezifische Arbeitsgruppe (FOSA, specialty- and organ-specific working group) founded for the field of nuclear medicine (FOSA Nuklearmedizin) within the NUM aim to initiate and coordinate measures in the context of digital medicine and (image-)data-driven analyses for the DGN.</p>","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":" ","pages":"276-283"},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Prof. Henryk Barthel, Oberarzt an der Klinik und Poliklinik für Nuklearmedizin des UKL, wurde auf der diesjährigen Tagung der US-amerikanischen Society of Nuclear Medicine and Molecular Imaging mit zwei Preisen ausgezeichnet: Zum einen erhielt er für seine wissenschaftlichen Leistungen der letzten Jahre den renommierten Kuhl-Lassen-Preis. Prof. Barthel erforscht neue Methoden der Hirn-PET-Bildgebung insbesondere bei neurodegenerativen Erkrankungen. Zum anderen wurde Prof. Barthel stellvertretend für das gesamte beteiligte Team für seinen aktuellen Tagungsbeitrag einer Multi-Zentrums-Studie zur Tau-PET-Bildgebung bei frontotemporaler Demenz mit dem Preis für das beste aus Deutschland eingereichte Abstract ausgezeichnet.
{"title":"Preisverleihungen","authors":"","doi":"10.1055/a-2158-4129","DOIUrl":"https://doi.org/10.1055/a-2158-4129","url":null,"abstract":"Prof. Henryk Barthel, Oberarzt an der Klinik und Poliklinik für Nuklearmedizin des UKL, wurde auf der diesjährigen Tagung der US-amerikanischen Society of Nuclear Medicine and Molecular Imaging mit zwei Preisen ausgezeichnet: Zum einen erhielt er für seine wissenschaftlichen Leistungen der letzten Jahre den renommierten Kuhl-Lassen-Preis. Prof. Barthel erforscht neue Methoden der Hirn-PET-Bildgebung insbesondere bei neurodegenerativen Erkrankungen. Zum anderen wurde Prof. Barthel stellvertretend für das gesamte beteiligte Team für seinen aktuellen Tagungsbeitrag einer Multi-Zentrums-Studie zur Tau-PET-Bildgebung bei frontotemporaler Demenz mit dem Preis für das beste aus Deutschland eingereichte Abstract ausgezeichnet.","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":"146 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134979025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01Epub Date: 2023-09-11DOI: 10.1055/a-2150-4130
Katharina Deininger, Joel Niclas Raacke, Elham Yousefzadeh-Nowshahr, Cornelia Kropf-Sanchen, Bernd Muehling, Meinrad Beer, Gerhard Glatting, Ambros J Beer, Wolfgang Thaiss
Aim: The aim of this study was to derive prognostic parameters from 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG-PET/CT) in patients with low-risk NSCLC and determine their prognostic value.
Methods: 81 (21 female, mean age 66 a) therapy-naive patients that underwent [18F]FDG-PET/CT before histologic confirmation of NSCLC with stadium I and II between 2008-2016 were included. A mean follow-up time of 58 months (13-176), overall and progression free survival (OS, PFS) were registered. A volume of interest for the primary tumor was defined on PET and CT images. Parameters SUVmax, PET-solidity, PET-circularity, and CT-volume were analyzed. To evaluate the prognostic value of each parameter for OS, a minimum p-value approach was used to define cutoff values, survival analysis, and log-rank tests were performed, including subgroup analysis for combinations of parameters.
Results: Mean OS was 58±28 months. Poor OS was associated with a tumor CT-volume >14.3 cm3 (p=0.02, HR=7.0, CI 2.7-17.7), higher SUVmax values >12.2 (p=0.003; HR=3.0, CI 1.3-6.7) and PET-solidity >0.919 (p=0.004; HR=3.0, CI 1.0-8.9). Combined parameter analysis revealed worse prognosis in larger volume/high SUVmax tumors compared to larger volume/lower SUVmax (p=0.028; HR=2.5, CI 1.1-5.5), high PET-solidity/low volume (p=0.01; HR=2.4, CI 0.8-6.6) and low SUVmax/high PET-solidity (p=0.02, HR=4.0, CI 0.8-19.0).
Conclusion: Even in this group of low-risk NSCLC patients, we identified a subgroup with a significantly worse prognosis by combining morphologic-metabolic biomarkers from [18F]FDG-PET/CT. The combination of SUVmax and CT-volume performed best. Based on these preliminary data, future prospective studies to validate this combined morphologic-metabolic imaging biomarker for potential therapeutic decisions seem promising.
{"title":"Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.","authors":"Katharina Deininger, Joel Niclas Raacke, Elham Yousefzadeh-Nowshahr, Cornelia Kropf-Sanchen, Bernd Muehling, Meinrad Beer, Gerhard Glatting, Ambros J Beer, Wolfgang Thaiss","doi":"10.1055/a-2150-4130","DOIUrl":"10.1055/a-2150-4130","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to derive prognostic parameters from 2-[<sup>18</sup>F]fluoro-2-deoxy-D-glucose ([<sup>18</sup>F]FDG-PET/CT) in patients with low-risk NSCLC and determine their prognostic value.</p><p><strong>Methods: </strong>81 (21 female, mean age 66 a) therapy-naive patients that underwent [18F]FDG-PET/CT before histologic confirmation of NSCLC with stadium I and II between 2008-2016 were included. A mean follow-up time of 58 months (13-176), overall and progression free survival (OS, PFS) were registered. A volume of interest for the primary tumor was defined on PET and CT images. Parameters SUV<sub>max</sub>, PET-solidity, PET-circularity, and CT-volume were analyzed. To evaluate the prognostic value of each parameter for OS, a minimum p-value approach was used to define cutoff values, survival analysis, and log-rank tests were performed, including subgroup analysis for combinations of parameters.</p><p><strong>Results: </strong>Mean OS was 58±28 months. Poor OS was associated with a tumor CT-volume >14.3 cm<sup>3</sup> (p=0.02, HR=7.0, CI 2.7-17.7), higher SUV<sub>max</sub> values >12.2 (p=0.003; HR=3.0, CI 1.3-6.7) and PET-solidity >0.919 (p=0.004; HR=3.0, CI 1.0-8.9). Combined parameter analysis revealed worse prognosis in larger volume/high SUV<sub>max</sub> tumors compared to larger volume/lower SUV<sub>max</sub> (p=0.028; HR=2.5, CI 1.1-5.5), high PET-solidity/low volume (p=0.01; HR=2.4, CI 0.8-6.6) and low SUV<sub>max</sub>/high PET-solidity (p=0.02, HR=4.0, CI 0.8-19.0).</p><p><strong>Conclusion: </strong>Even in this group of low-risk NSCLC patients, we identified a subgroup with a significantly worse prognosis by combining morphologic-metabolic biomarkers from [18F]FDG-PET/CT. The combination of SUV<sub>max</sub> and CT-volume performed best. Based on these preliminary data, future prospective studies to validate this combined morphologic-metabolic imaging biomarker for potential therapeutic decisions seem promising.</p>","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":" ","pages":"284-292"},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10210208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nach drei Jahren Corona-Pause konnten in diesem Jahr vom 28. bis 30. Juni 2023 wieder die traditionsreichen Hamburger Nuklearmedizin-Tage im Hotel Engel stattfinden. 30 (überwiegend) junge Kolleg:innen waren gekommen, um sich über drei Tage in praxisrelevanten nuklearmedizinischen Themen fortzubilden.
{"title":"27. Hamburger Nuklearmedizin-Tage 28.–30.6.2023","authors":"","doi":"10.1055/a-2150-6076","DOIUrl":"https://doi.org/10.1055/a-2150-6076","url":null,"abstract":"Nach drei Jahren Corona-Pause konnten in diesem Jahr vom 28. bis 30. Juni 2023 wieder die traditionsreichen Hamburger Nuklearmedizin-Tage im Hotel Engel stattfinden. 30 (überwiegend) junge Kolleg:innen waren gekommen, um sich über drei Tage in praxisrelevanten nuklearmedizinischen Themen fortzubilden.","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134979181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nach durchweg positivem Feedback der Teilnehmenden der Auftaktveranstaltung vergangenes Jahr im thüringischen Eisenach hat sich die DGN-Arbeitsgemeinschaft „Young DGN“ dazu entschlossen, das Format erneut anzubieten und künftig im Fortbildungskalender zu etablieren. Das Programm soll jüngere Vertreterinnen sowie Vertreter aller durch die Nuklearmedizin vereinigten Berufsgruppen ansprechen und ist auf Soft Skills fokussiert, welche bei Fachkongressen nicht adäquat berücksichtigt werden können. Schwerpunkte der diesjährigen „Young DGN Autumn School“, welche am 17. und 18. November 2023 in Frankfurt am Main stattfindet, werden Stressmanagement und interkulturelle Kommunikation sein. Darüber hinaus gibt das Format dem nuklearmedizinischen Nachwuchs Gelegenheit zur Vernetzung. Weitere Informationen sind der „Young DGN“-Online-Präsenz zu entnehmen und Bewerbungen per E-Mail an youngdgn@nuklearmedizin.de zu richten. Die Kursgebühren sowie Hotelkosten der ausgewählten Kandidatinnen und Kandidaten werden durch ein Stipendium gedeckt. Die Organisation der „Young DGN Autumn School“ wird von Frau Dr. Elena Jaeger, Frau Dr. Yasemin Aylin Sahin, Herrn Johannes Kunz und Herrn Dr. Conrad-Amadeus Voltin übernommen.
{"title":"„Young DGN Autumn School“ geht in die zweite Runde","authors":"","doi":"10.1055/a-2153-2709","DOIUrl":"https://doi.org/10.1055/a-2153-2709","url":null,"abstract":"Nach durchweg positivem Feedback der Teilnehmenden der Auftaktveranstaltung vergangenes Jahr im thüringischen Eisenach hat sich die DGN-Arbeitsgemeinschaft „Young DGN“ dazu entschlossen, das Format erneut anzubieten und künftig im Fortbildungskalender zu etablieren. Das Programm soll jüngere Vertreterinnen sowie Vertreter aller durch die Nuklearmedizin vereinigten Berufsgruppen ansprechen und ist auf Soft Skills fokussiert, welche bei Fachkongressen nicht adäquat berücksichtigt werden können. Schwerpunkte der diesjährigen „Young DGN Autumn School“, welche am 17. und 18. November 2023 in Frankfurt am Main stattfindet, werden Stressmanagement und interkulturelle Kommunikation sein. Darüber hinaus gibt das Format dem nuklearmedizinischen Nachwuchs Gelegenheit zur Vernetzung. Weitere Informationen sind der „Young DGN“-Online-Präsenz zu entnehmen und Bewerbungen per E-Mail an youngdgn@nuklearmedizin.de zu richten. Die Kursgebühren sowie Hotelkosten der ausgewählten Kandidatinnen und Kandidaten werden durch ein Stipendium gedeckt. Die Organisation der „Young DGN Autumn School“ wird von Frau Dr. Elena Jaeger, Frau Dr. Yasemin Aylin Sahin, Herrn Johannes Kunz und Herrn Dr. Conrad-Amadeus Voltin übernommen.","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135606016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Im Rahmen der NuklearMedizin 2024, der 62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin, die vom 10. bis 13. April 2024 in Leipzig stattfindet, werden folgende Preise vergeben:
{"title":"DGN-Forschungs- und -Förderpreise","authors":"","doi":"10.1055/a-2150-6091","DOIUrl":"https://doi.org/10.1055/a-2150-6091","url":null,"abstract":"Im Rahmen der NuklearMedizin 2024, der 62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin, die vom 10. bis 13. April 2024 in Leipzig stattfindet, werden folgende Preise vergeben:","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134979024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Noch bis zum 1. November 2023 um 14.00 Uhr ist es möglich, Abstracts für die kommende 62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig einzureichen. Der Kongresskoordinator, Prof. Dr. Kambiz Rahbar (Bonn), freut sich über zahlreiche interessante Beiträge. Sie können Ihre Beiträge online auf der Kongresshomepage nukmed24.nuklearmedizin.de unter „Abstracts“ einreichen. Nach dem Ende der Abstracteinreichung erfolgt die Begutachtung durch das wissenschaftliche Komitee.
{"title":"NuklearMedizin 2024: Abstract-Einreichung bis zum 1. November geöffnet!","authors":"","doi":"10.1055/a-2150-6061","DOIUrl":"https://doi.org/10.1055/a-2150-6061","url":null,"abstract":"Noch bis zum 1. November 2023 um 14.00 Uhr ist es möglich, Abstracts für die kommende 62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig einzureichen. Der Kongresskoordinator, Prof. Dr. Kambiz Rahbar (Bonn), freut sich über zahlreiche interessante Beiträge. Sie können Ihre Beiträge online auf der Kongresshomepage nukmed24.nuklearmedizin.de unter „Abstracts“ einreichen. Nach dem Ende der Abstracteinreichung erfolgt die Begutachtung durch das wissenschaftliche Komitee.","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134979022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号